Edgestream Partners, L.P. Innoviva, Inc. Transaction History
Edgestream Partners, L.P.
- $3.48 Billion
- Q2 2025
A detailed history of Edgestream Partners, L.P. transactions in Innoviva, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 37,959 shares of INVA stock, worth $663,523. This represents 0.02% of its overall portfolio holdings.
Number of Shares
37,959Holding current value
$663,523% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding INVA
# of Institutions
283Shares Held
80.4MCall Options Held
10.3KPut Options Held
161K-
Black Rock Inc. New York, NY9.63MShares$168 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.18MShares$125 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$110 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.76MShares$83.2 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.29MShares$75.1 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.22B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...